Back to User profile » Professor Bartolomé Celli

Papers published by Professor Bartolomé Celli:


Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease

Giraldo-Montoya ÁM, Torres-Duque CA, Giraldo-Cadavid LF, Laucho-Contreras ME, González-Flórez A, Santos AM, Tuta-Quintero EA, Celli BR, González-García M

International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1-10

Published Date: 30 December 2023

GOLD 2023 Update: Implications for Clinical Practice

Tamondong-Lachica DR, Skolnik N, Hurst JR, Marchetti N, Rabe APJ, Montes de Oca M, Celli BR

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:745-754

Published Date: 5 May 2023

New Perspectives on Chronic Obstructive Pulmonary Disease

Celli BR, Singh D, Vogelmeier C, Agusti A

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2127-2136

Published Date: 6 September 2022

Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial

Bradbury T, Di Tanna GL, Scaria A, Martin A, Wen FQ, Zhong NS, Zheng JP, Barnes PJ, Celli B, Berend N, Jenkins CR

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:273-282

Published Date: 5 February 2022

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients

López-Campos JL, Alcázar Navarrete B, Riesco Miranda JA, Cosío BG, de-Torres JP, Celli B, Jiménez-Ruiz CA, Casanova Macario C

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1801-1811

Published Date: 27 July 2020

FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease

Bikov A, Lange P, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Yates JC, Vestbo J

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1135-1142

Published Date: 20 May 2020

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3971-3981

Published Date: 12 December 2018

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study

Celli B, Blasi F, Gaga M, Singh D, Vogelmeier C, Pegoraro V, Caputo N, Agusti A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2189-2196

Published Date: 27 July 2017

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study

Cabrera C, Casanova C, Martín Y, Mirabal V, Sánchez MC, Álvarez F, Juliá G, Cabrera-Navarro P, García-Bello MA, Marín JM, de-Torres JP, Divo M, Celli B

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1217-1222

Published Date: 8 June 2016

Exacerbation frequency and course of COPD

Halpin DMG, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:653-661

Published Date: 21 September 2012

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials

Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I, Kesten S

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:269-275

Published Date: 9 May 2011